Item 7.01.  Regulation FD Disclosure.
On January 11, 2022, Endo International plc (the "Company") intends to make a
presentation at the J.P. Morgan Healthcare Conference (the "Presentation"), a
copy of which is furnished as Exhibit 99.1 hereto and is incorporated herein by
reference. The Presentation will also be available on the Company's website at
www.endo.com.
The information in this Item 7.01 and in Exhibit 99.1 attached hereto shall not
be deemed to be "filed" for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of that
section. The information contained in this Item 7.01 and in Exhibit 99.1
attached hereto shall not be incorporated into any registration statement or
other document filed by the Company with the U.S. Securities and Exchange
Commission under the Securities Act of 1933, whether made before or after the
date hereof, regardless of any general incorporation language in such filing,
except as shall be expressly set forth by specific reference in such filing.
Item 9.01.  Financial Statements and Exhibits.
(d) Exhibits.
Number     Description
99.1         Investor Presentation of Endo International plc dated as of January 11, 2022
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses